Skip to main content
Signal8

Jones Susan Dana

SEC insider (Form 3/4/5 filer). CIK 0001995339. Chief Technology Officer at Tourmaline Bio, Inc. (TRML). 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 28, 2025. Located in NEW YORK, NY.

Companies Jones Susan Dana has filed insider reports for

  • Tourmaline Bio, Inc. (TRML): Officer, Chief Technology Officer
Jones Susan Dana profile photo

Jones Susan Dana

CIK: 0001995339

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tourmaline Bio, Inc. logo
TRML

Tourmaline Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tourmaline Bio, Inc. logo
    TRML

    Tourmaline Bio, Inc.

    Oct 28, 2025
    Tender Offer
    Direct
    19.8K shares-
  • Tourmaline Bio, Inc. logo
    TRML

    Tourmaline Bio, Inc.

    Oct 28, 2025
    Disposition
    Direct
    3.2K shares-
  • Tourmaline Bio, Inc. logo
    TRML

    Tourmaline Bio, Inc.

    Jan 27, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    58K shares-

1-3 of 3